Cizzle Bio, Inc.

10/16/2026

Questions about lung cancer risk deserve an informed conversation. If you live in the San Antonio area, consider asking your healthcare provider about your personal risk factors, LDCT screening eligibility, and whether additional assessment may be appropriate.

Patient information:
https://go.cizzlebio.com/dsuWuE

10/15/2026

San Antonio-area healthcare providers can review clinical information and ordering setup steps for the CIZ1B Biomarker Blood Test for Lung Cancer.

Provider resources:
https://go.cizzlebio.com/rBaktj

10/13/2026

Licensed healthcare providers in Dallas–Fort Worth can begin CIZ1B test ordering setup and receive follow-up guidance covering onboarding, ordering, specimen collection, and results access.

Provider information:
https://go.cizzlebio.com/BQvp7M

10/13/2026

Moving cancer research forward takes collaboration.

Dr. Steven T. Rosen, Scientific Advisor to Cizzle Bio, joined leading cancer researchers on October 6 for a panel discussion at the Global Cancer Research & Innovation Symposium (GCRIS) in New York City.

His participation highlights the scientific expertise guiding our work on the CIZ1B Biomarker Blood Test for Lung Cancer—designed to complement standard-of-care diagnostics and support clinical decision-making.

Read the full press release for Dr. Rosen’s perspective and the latest updates on CIZ1B research and availability: https://go.cizzlebio.com/fXJhNW


Association for Value-Based Cancer Care

/PRNewswire/ -- Dr. Steven T. Rosen, scientific advisor to Cizzle Bio and a globally recognized leader in cancer research and translational medicine, joined...

10/13/2026

LDCT and biomarker blood testing provide different types of information. The CIZ1B test is designed to complement established clinical approaches—not replace them.

Read the article:
https://go.cizzlebio.com/MM4Vn4

10/12/2026

We’re looking forward to the 4th Annual Doc-to-Doc Meet and Greet on October 14 at the McKenna Events Center in New Braunfels.

This event brings together physicians and healthcare professionals from across the Hill Country to build stronger referral relationships, improve communication and support better continuity of care for patients.

Attending? Stop by to meet the Cizzle Bio team and learn more about our work in early cancer detection.

Learn more: https://go.cizzlebio.com/URCnXK


Texas Academy of Family Physicians

Cizzle Bio will participate in the 4th Annual Doc-to-Doc Meet and Greet, connecting with Hill Country physicians and healthcare professionals in New Braunfels.

10/12/2026

An evening of light. A community of hope. ❤️

This past weekend, Cizzle Bio attended Blood Cancer United’s Light The Night, joining a community united in support of people affected by blood cancer.

We were proud to be there to celebrate survivors, honor loved ones, and stand with patients and families. Thank you to Blood Cancer United and everyone who helped make the evening a reminder of the power of community, compassion, and hope.


Blood Cancer United

10/12/2026

An evening of light. A community of hope. ❤️

This past weekend, Cizzle Bio attended Blood Cancer United’s Light The Night, joining a community united in support of people affected by blood cancer.

We were proud to be there to celebrate survivors, honor loved ones, and stand with patients and families. Thank you to Blood Cancer United and everyone who helped make the evening a reminder of the power of community, compassion, and hope.

10/08/2026

A moment from GCRIS 2026 in New York City!

Dr. Steven Rosen, Cizzle Bio’s Scientific Advisor and Provost and Chief Scientific Officer at City of Hope, joined fellow cancer research leaders for the panel “Swim Across America Pioneers: ‘What We are Doing in Our Labs Today?’”

His participation highlights the scientific expertise guiding Cizzle Bio as we continue advancing the CIZ1B Biomarker Blood Test for Lung Cancer and our broader biomarker strategy.

Thank you to the Association for Value-Based Cancer Care and Swim Across America for bringing together researchers and leaders working toward new advances in cancer detection and care.


Association for Value-Based Cancer Care

10/06/2026

We’re highlighting the scientific expertise guiding Cizzle Bio at the Global Cancer Research & Innovation Symposium (GCRIS) in New York City!
Dr. Steven Rosen, Cizzle Bio’s Scientific Advisor and Provost and Chief Scientific Officer at City of Hope, will join the panel “Swim Across America Pioneers: ‘What We are Doing in Our Labs Today?’” on October 6, 2026, from 5–6 p.m. EDT at the New York Athletic Club.

Dr. Rosen’s leadership in cancer research and the advancement of new approaches to cancer detection and care helps guide our work as we continue advancing the CIZ1B Biomarker Blood Test for Lung Cancer and our broader biomarker strategy.

We look forward to hearing from Dr. Rosen and fellow cancer research leaders about the work underway in their labs and its potential to advance cancer care.

Learn more: https://go.cizzlebio.com/3VLzUM


Association for Value-Based Cancer Care

Cizzle Bio highlights Scientific Advisor Dr. Steven Rosen’s GCRIS 2026 panel and the expertise guiding its CIZ1B lung cancer biomarker blood test.